Skip to Main Content
ニュース&イベント: 雇用/労働法/福利厚生関連情報

【雇用法フラッシュニュース】従業員の休職に際して検討すべき団体保険プラン

3.31.22

When considering whether to approve an employee’s leave of absence request or upon learning that an employee will be away from work for an extended period due to a work-related injury, few employers confirm the permitted “coverage extension” provision in their group health insurance plan document. Instead, many employers simply allow such employees to continue their group health insurance coverage for months or years under the active employee group health insurance plan.

Although some leaves of absence are protected (i.e., FMLA) and may require an employer to continue an employee’s active group health insurance for a specified period of time, many leaves of absence are not protected by a federal or state statute. As a result, an employee on an unprotected leave of absence may be entitled to remain on the active employee plan for a limited period of time. Some group insurance plans require that an employee’s active insurance coverage be terminated on the last day of the month in which the leave of absence begins, or a few months later. In short, active group health insurance coverage for an employee on a leave of absence may need to be terminated based on the terms of the group insurance contract. This loss of insurance coverage is both required by the group health insurance plan provisions and a qualifying event under the Consolidated Omnibus Budget Reconciliation Act (COBRA) or state equivalent law.

To avoid employees being improperly retained on the active employee group health insurance plan during a leave of absence, employers should review their group health insurance plan documents to confirm the maximum period of time that employees are permitted to be retained on the active group health insurance plan before being offered COBRA continuation coverage. Because the plan document language may be vague, employers should contact their insurance brokers and/or call their Masuda Funai relationship attorney for a proper interpretation.

© 2022 Masuda, Funai, Eifert & Mitchell, Ltd. All rights reserved. 本書は、特定の事実や状況に関する法務アドバイスまたは法的見解に代わるものではありません。本書に含まれる内容は、情報の提供を目的としたものです。かかる情報を利用なさる場合は、弁護士にご相談の上、アドバイスに従ってください。本書は、広告物とみなされることもあります。